The anti-proliferative and anti-angiogenic potential of the combination of 4-HPR and GST in RD-ES xenografts were due to inhibition of the survival factor NF-κB and the angiogenic factors VEGF and FGF2 (Fig. 4B). The gene discussed is VEGFA; the disease is Ewing sarcoma.